Cargando…

Continuous ST‐Monitoring Function of Implantable Cardioverter Defibrillator Detects Silent Ischemia in Patients With Coronary Artery Disease

BACKGROUND: Newer implantable cardioverter defibrillators can monitor intracardiac ECGs , but their ability to detect ischemia is unclear. This study investigated the usefulness of implantable cardioverter defibrillators with an ST‐monitoring function in coronary artery disease patients. METHODS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Tetsuya, Hirooka, Keiji, Furukawa, Yoshio, Yabuki, Masanori, Hirata, Akio, Kashiwase, Kazunori, Shutta, Ryu, Mine, Takanao, Mizuno, Hiroya, Tanaka, Toshikazu, Doi, Takahiro, Yoshida, Akihiro, Okuyama, Yuji, Nanto, Shinsuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064887/
https://www.ncbi.nlm.nih.gov/pubmed/29960992
http://dx.doi.org/10.1161/JAHA.118.009332
_version_ 1783342773887303680
author Watanabe, Tetsuya
Hirooka, Keiji
Furukawa, Yoshio
Yabuki, Masanori
Hirata, Akio
Kashiwase, Kazunori
Shutta, Ryu
Mine, Takanao
Mizuno, Hiroya
Tanaka, Toshikazu
Doi, Takahiro
Yoshida, Akihiro
Okuyama, Yuji
Nanto, Shinsuke
author_facet Watanabe, Tetsuya
Hirooka, Keiji
Furukawa, Yoshio
Yabuki, Masanori
Hirata, Akio
Kashiwase, Kazunori
Shutta, Ryu
Mine, Takanao
Mizuno, Hiroya
Tanaka, Toshikazu
Doi, Takahiro
Yoshida, Akihiro
Okuyama, Yuji
Nanto, Shinsuke
author_sort Watanabe, Tetsuya
collection PubMed
description BACKGROUND: Newer implantable cardioverter defibrillators can monitor intracardiac ECGs , but their ability to detect ischemia is unclear. This study investigated the usefulness of implantable cardioverter defibrillators with an ST‐monitoring function in coronary artery disease patients. METHODS AND RESULTS: We conducted a prospective study of implantable cardioverter defibrillator patients with the ST‐monitoring function. One hundred seventy‐three patients who received implantable cardioverter defibrillators for primary or secondary prevention of sudden cardiac death. All patients underwent medical examinations at least every 6 months, with standard 12‐lead ECGs and device checks that included analysis of the ST‐monitoring function. Myocardial perfusion imaging or coronary angiography was performed during the follow‐up. The mean follow‐up duration was 23.3±7.7 months. Significant ST changes occurred in 15 patients (8.7%), of whom 14 were asymptomatic. The incidence of angina pectoris was significantly higher in the ST change (+) group than that in the ST change (−) group (28.6% versus 7.2%, P=0.03). In the patients who underwent myocardial perfusion imaging, the sensitivity, specificity, and negative predictive value of the ST‐monitoring feature to detect ischemia were 75.0%, 72.5%, and 93.5%, respectively. The sensitivity, specificity, and negative predictive value of the ST‐monitoring feature to predict residual stenosis evaluated using coronary angiography were 76.9%, 83.5%, and 97.5%, respectively. The percentage of patients with a septal right ventricular lead was significantly lower in the ST change (+) group than in the ST change (−) group (13.5% versus 33.5%, P=0.01). CONCLUSIONS: If intracardiac ECGs ST changes are detected, it is necessary to use additional modalities even in asymptomatic patients. CLINICAL TRIAL REGISTRATION: URL: http://upload.umin.ac.jp. Unique identifier: UMIN000011824.
format Online
Article
Text
id pubmed-6064887
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-60648872018-08-09 Continuous ST‐Monitoring Function of Implantable Cardioverter Defibrillator Detects Silent Ischemia in Patients With Coronary Artery Disease Watanabe, Tetsuya Hirooka, Keiji Furukawa, Yoshio Yabuki, Masanori Hirata, Akio Kashiwase, Kazunori Shutta, Ryu Mine, Takanao Mizuno, Hiroya Tanaka, Toshikazu Doi, Takahiro Yoshida, Akihiro Okuyama, Yuji Nanto, Shinsuke J Am Heart Assoc Original Research BACKGROUND: Newer implantable cardioverter defibrillators can monitor intracardiac ECGs , but their ability to detect ischemia is unclear. This study investigated the usefulness of implantable cardioverter defibrillators with an ST‐monitoring function in coronary artery disease patients. METHODS AND RESULTS: We conducted a prospective study of implantable cardioverter defibrillator patients with the ST‐monitoring function. One hundred seventy‐three patients who received implantable cardioverter defibrillators for primary or secondary prevention of sudden cardiac death. All patients underwent medical examinations at least every 6 months, with standard 12‐lead ECGs and device checks that included analysis of the ST‐monitoring function. Myocardial perfusion imaging or coronary angiography was performed during the follow‐up. The mean follow‐up duration was 23.3±7.7 months. Significant ST changes occurred in 15 patients (8.7%), of whom 14 were asymptomatic. The incidence of angina pectoris was significantly higher in the ST change (+) group than that in the ST change (−) group (28.6% versus 7.2%, P=0.03). In the patients who underwent myocardial perfusion imaging, the sensitivity, specificity, and negative predictive value of the ST‐monitoring feature to detect ischemia were 75.0%, 72.5%, and 93.5%, respectively. The sensitivity, specificity, and negative predictive value of the ST‐monitoring feature to predict residual stenosis evaluated using coronary angiography were 76.9%, 83.5%, and 97.5%, respectively. The percentage of patients with a septal right ventricular lead was significantly lower in the ST change (+) group than in the ST change (−) group (13.5% versus 33.5%, P=0.01). CONCLUSIONS: If intracardiac ECGs ST changes are detected, it is necessary to use additional modalities even in asymptomatic patients. CLINICAL TRIAL REGISTRATION: URL: http://upload.umin.ac.jp. Unique identifier: UMIN000011824. John Wiley and Sons Inc. 2018-06-30 /pmc/articles/PMC6064887/ /pubmed/29960992 http://dx.doi.org/10.1161/JAHA.118.009332 Text en © 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Watanabe, Tetsuya
Hirooka, Keiji
Furukawa, Yoshio
Yabuki, Masanori
Hirata, Akio
Kashiwase, Kazunori
Shutta, Ryu
Mine, Takanao
Mizuno, Hiroya
Tanaka, Toshikazu
Doi, Takahiro
Yoshida, Akihiro
Okuyama, Yuji
Nanto, Shinsuke
Continuous ST‐Monitoring Function of Implantable Cardioverter Defibrillator Detects Silent Ischemia in Patients With Coronary Artery Disease
title Continuous ST‐Monitoring Function of Implantable Cardioverter Defibrillator Detects Silent Ischemia in Patients With Coronary Artery Disease
title_full Continuous ST‐Monitoring Function of Implantable Cardioverter Defibrillator Detects Silent Ischemia in Patients With Coronary Artery Disease
title_fullStr Continuous ST‐Monitoring Function of Implantable Cardioverter Defibrillator Detects Silent Ischemia in Patients With Coronary Artery Disease
title_full_unstemmed Continuous ST‐Monitoring Function of Implantable Cardioverter Defibrillator Detects Silent Ischemia in Patients With Coronary Artery Disease
title_short Continuous ST‐Monitoring Function of Implantable Cardioverter Defibrillator Detects Silent Ischemia in Patients With Coronary Artery Disease
title_sort continuous st‐monitoring function of implantable cardioverter defibrillator detects silent ischemia in patients with coronary artery disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064887/
https://www.ncbi.nlm.nih.gov/pubmed/29960992
http://dx.doi.org/10.1161/JAHA.118.009332
work_keys_str_mv AT watanabetetsuya continuousstmonitoringfunctionofimplantablecardioverterdefibrillatordetectssilentischemiainpatientswithcoronaryarterydisease
AT hirookakeiji continuousstmonitoringfunctionofimplantablecardioverterdefibrillatordetectssilentischemiainpatientswithcoronaryarterydisease
AT furukawayoshio continuousstmonitoringfunctionofimplantablecardioverterdefibrillatordetectssilentischemiainpatientswithcoronaryarterydisease
AT yabukimasanori continuousstmonitoringfunctionofimplantablecardioverterdefibrillatordetectssilentischemiainpatientswithcoronaryarterydisease
AT hirataakio continuousstmonitoringfunctionofimplantablecardioverterdefibrillatordetectssilentischemiainpatientswithcoronaryarterydisease
AT kashiwasekazunori continuousstmonitoringfunctionofimplantablecardioverterdefibrillatordetectssilentischemiainpatientswithcoronaryarterydisease
AT shuttaryu continuousstmonitoringfunctionofimplantablecardioverterdefibrillatordetectssilentischemiainpatientswithcoronaryarterydisease
AT minetakanao continuousstmonitoringfunctionofimplantablecardioverterdefibrillatordetectssilentischemiainpatientswithcoronaryarterydisease
AT mizunohiroya continuousstmonitoringfunctionofimplantablecardioverterdefibrillatordetectssilentischemiainpatientswithcoronaryarterydisease
AT tanakatoshikazu continuousstmonitoringfunctionofimplantablecardioverterdefibrillatordetectssilentischemiainpatientswithcoronaryarterydisease
AT doitakahiro continuousstmonitoringfunctionofimplantablecardioverterdefibrillatordetectssilentischemiainpatientswithcoronaryarterydisease
AT yoshidaakihiro continuousstmonitoringfunctionofimplantablecardioverterdefibrillatordetectssilentischemiainpatientswithcoronaryarterydisease
AT okuyamayuji continuousstmonitoringfunctionofimplantablecardioverterdefibrillatordetectssilentischemiainpatientswithcoronaryarterydisease
AT nantoshinsuke continuousstmonitoringfunctionofimplantablecardioverterdefibrillatordetectssilentischemiainpatientswithcoronaryarterydisease